Skip to main content
OpenTrials
Recruiting

NCT Number: NCT04569162

Rhizomelic Chondrodysplasia Punctata Registry

The goal of this registry is to collect medical information on individuals with rhizomelic chondrodysplasia punctata and closely related conditions. The study team hopes to learn more about these conditions and improve the care of people with it by establishing this registry.

Recruiting

Interested in participating?

Request Info

Key information

About this study

The goal of this registry is to collect information on individuals with rhizomelic chondrodysplasia punctata (also called RCDP). This registry will enable detailed natural history studies of RCDP, with the hopes that identification of risk factors will allow for preventative treatments and thus a better quality of life for individuals with these diagnoses.

This study is limited to chart review, after signed informed consent obtained. There will be no additional visits or time in clinic because of participation in this registry. This study involves only the collection and storage of data extracted from the medical record. Records that may be requested and reviewed as a part of this study include but may not be limited to: specialist evaluations, surgical reports, results of blood and urine tests, genetic testing, x-rays, CT/MRI imaging. There are no special procedures, visits, or expectations of the individual as a result of participation in this registry. No one will be asked to have any specific testing for the sole purposes of this research.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Diagnosed with RCDP or closely related conditions by metabolic and/or genetic testing

Exclusion criteria

  • Not meeting diagnosis of RCDP or closely related conditions by study team physician review of prior metabolic and/or genetic testing

Treatment and study plan

Primary outcomes

  1. Characterizations of the natural history of rhizomelic chondrodysplasia punctata

    Time frame: 5 years

    Data will be collected at enrollment, and over time, to allow for analysis of associated features throughout the lifespan

  2. Identification of clinical features that are predictive of poor outcomes

    Time frame: 5 years

    Identifying risk factors will allow for preventative treatments and thus a better quality of life for individuals with RCDP.

Study contacts

Contact information is provided by the study sponsor or research team.

Emily Longenecker, BS

CONTACT

[email protected]

302-298-7978

Sponsors and collaborators

Lead sponsor

Nemours Children's Clinic

Other

Collaborators

  • RhizoKids International

Registry information

Official study title

Rhizomelic Chondrodysplasia Punctata Registry at Nemours Children's Health

Important dates

Study start
2013
Primary completion
2030
Study completion
2030
First posted
Sep 29, 2020
Registry last updated
Jul 11, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.